EVLO (Evelo Biosciences) OCF Margin %: 0.00% (As of Sep. 2023)


What is Evelo Biosciences OCF Margin %?

Evelo Biosciences EVLO -99.00% OCF Margin % is 0.00% as of Sep. 2023.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Evelo Biosciences's Cash Flow from Operations for the three months ended in Sep. 2023 was $-10.41 Mil. Evelo Biosciences's Revenue for the three months ended in Sep. 2023 was $0.00 Mil. Therefore, Evelo Biosciences's OCF Margin % for the quarter that ended in Sep. 2023 was 0.00%.

As of today, Evelo Biosciences's current OCF Yield % is -400,600.00%.

The historical rank and industry rank for Evelo Biosciences's OCF Margin % or its related term are showing as below:


EVLO's OCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -66.52
* Ranked among companies with meaningful OCF Margin % only.

Evelo Biosciences OCF Margin % Related Terms

Evelo Biosciences OCF Margin % Historical Data

* Premium members only.

The historical data trend for Evelo Biosciences's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Evelo Biosciences OCF Margin % Chart

Evelo Biosciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
OCF Margin %
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Evelo Biosciences Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Evelo Biosciences OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Evelo Biosciences's OCF Margin for the fiscal year that ended in Dec. 2022 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2022 )/Revenue (A: Dec. 2022 )
=-101.235/0
= %

Evelo Biosciences's OCF Margin for the quarter that ended in Sep. 2023 is calculated as

OCF Margin=Cash Flow from Operations (Q: Sep. 2023 )/Revenue (Q: Sep. 2023 )
=-10.408/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 0.00% mean?
Evelo Biosciences (EVLO) has a OCF Margin % of 0.00% as of Sep. 2023. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Evelo Biosciences and its competitors.
Is Evelo Biosciences' OCF Margin % too high?
Evelo Biosciences' current OCF Margin % is 0.00%.
How does Evelo Biosciences' OCF Margin % compare to IMNN and EDSA?
Evelo Biosciences' OCF Margin % of 0.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Evelo Biosciences and its competitors. Evelo Biosciences's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Evelo Biosciences stock overvalued right now?
Evelo Biosciences (EVLO) has a current OCF Margin % of 0.00%. The current OCF Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Evelo Biosciences (EVLO), the current OCF Margin % is 0.00% as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Evelo Biosciences Business Description

Address 620 Memorial Drive, Cambridge, MA, USA, 02139
Evelo Biosciences Inc is a clinical-stage biotechnology company focused on discovering and developing a new class of oral medicines that act on immune cells in the small intestine with systemic effects. The company is developing EDP1815 as a treatment in psoriasis and atopic dermatitis and EDP2939 in psoriasis.